ArticleFrontiers in genetics2026
SIGMA: self-supervised inference of gene networks via masked auto-encoding.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Inferring gene regulatory networks (GRNs) from expression profiles is essential for identifying critical genes within complex disease pathways. However, current machine learning-based GRN inference methods face two challenges. Unsupervised methods struggle to achieve satisfactory accuracy in inference, while supervised methods are limited by the scarcity of high-quality interaction labels. Further, existing models demonstrate significant shortcomings when it comes to transferring reasoning to other GRN task subtypes. These issues affect GRN inference and hinder the ability to discover new regulatory patterns. Findings: To address these challenges, we have developed SIGMA: a transformer-based framework that uses self-supervised learning to pretrain the encoder on expression profiles. This alleviates the need for high-quality labels. During pretraining, it converts gene expression pairs into non-overlapping patches, and randomly masks some of these patches. This forces the encoder to extract correlation representations from the unmasked patches without label guidance, enabling the decoder to reconstruct the masked patches while preserving their similarity. Experiments have demonstrated that the pretrained encoder can accurately infer GRNs and be used to infer other subtypes, thereby reducing reliance on labels. Benchmark tests on human and mouse datasets have shown that SIGMA outperforms state-of-the-art methods. When applied to breast cancer datasets, SIGMA produced predictions that were consistent with established networks and identified candidate interactions that were not present in the gold-standard networks. Further investigation and experimental validation of these relationships is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.